Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2
Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › Letter
Author(s)
Related Research Unit(s)
Detail(s)
Original language | English |
---|---|
Article number | 168 |
Journal / Publication | Signal Transduction and Targeted Therapy |
Volume | 6 |
Online published | 24 Apr 2021 |
Publication status | Published - 2021 |
Link(s)
DOI | DOI |
---|---|
Attachment(s) | Documents
Publisher's Copyright Statement
|
Link to Scopus | https://www.scopus.com/record/display.uri?eid=2-s2.0-85104896139&origin=recordpage |
Permanent Link | https://scholars.cityu.edu.hk/en/publications/publication(49ed11cb-5608-455d-893b-2fa2aabc1d02).html |
Research Area(s)
Citation Format(s)
Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2. / Huang, Lihong; Yuen, Terrence Tsz-Tai; Ye, Zuodong; Liu, Shuyan; Zhang, Guoliang; Chu, Hin; Yue, Jianbo.
In: Signal Transduction and Targeted Therapy, Vol. 6, 168, 2021.Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › Letter
Download Statistics
No data available